Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - A case series

International Journal of Artificial Organs

Volumn 40, Issue 5, 2017, Pages 240-249

  Träger, Karl ^a   Skrabal, Christian ^a   Fischer, Guenther ^a   Datzmann, Thomas ^a   Schroeder, Janpeter ^a   Fritzler, Daniel ^a   Hartmann, Jan ^a   Liebold, Andreas ^a   Reinelt, Helmut ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cardiopulmonary bypass; Cytokines; CytoSorb; Hemoadsorption; Infective endocarditis

Indexed keywords

CARDIOVASCULAR SURGERY;

CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; CYTOKINES; CYTOSORB; HAEMODYNAMICS; HEMOADSORPTION; INFECTIVE ENDOCARDITIS; INTRA-OPERATIVE; ORGAN FUNCTIONS; VALVE REPLACEMENT;

HEMODYNAMICS;

CYTOKINE; EPINEPHRINE; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN;

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL ENDOCARDITIS; BLOOD FILTER; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; CORYNEBACTERIUM; CRITICALLY ILL PATIENT; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EUROSCORE; FEMALE; HEMADSORPTION; HEMODYNAMICS; HEMOPERFUSION; HUMAN; LENGTH OF STAY; MALE; METABOLIC PARAMETERS; NONHUMAN; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; SURVIVAL RATE; ADULT; AGED; BLOOD; ENDOCARDITIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; COMBINED MODALITY THERAPY; CYTOKINES; ENDOCARDITIS; FEMALE; HEMADSORPTION; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 85020216019     PISSN: 03913988     EISSN: 17246040     Source Type: Journal    
DOI: 10.5301/ijao.5000583     Document Type: Article

References (16)

1. Carrel T, Englberger L, Takala J. Whats new in surgical treatment of infective endocarditis? Intensive Care Med. 2016; 42 (12): 2052-2054.
2. The 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015; 36 (44): 3036-3037.
3. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996; 61 (6): 1714-1720.
4. Born F, Pichlmaier M, Peterß S, et al. Systemic Inflammatory Response Syndrome in in Heart Surgery: New possibilities for treatment through the use of a cytokine adsorber during ECC? Kardiotechnik. 2014; 2: 1-10 http://armaghansalamat.com/ media/brands/Cytosorbents/Literature/2014_Born%20F%20 et%20al., %20Systemic%20Inflammatory%20Response%20 Syndrome%20in%20der%20Herzchirurgie_Kardiotechnik%20 02-2014%20-%20English%20Translation.pdf.Accessed April 24, 2017.
5. Träger K, Fritzler D, Fischer G, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016; 39 (3): 141-146.
6. Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012; 41 (4): 734-744, discussion 744-745.
7. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves shortterm survival in lethal endotoxemia. Crit Care Med. 2004; 32 (3): 801-805.
8. Kuntsevich VI, Feinfeld DA, Audia PF, et al. In-vitro myoglobin clearance by a novel sorbent system. Artif Cells Blood Substit Immobil Biotechnol. 2009; 37 (1): 45-47.
9. Hetz H, Berger R, Recknagel P, Steltzer H. Septic shock secondary to β-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014; 37 (5): 422-426.
10. Schädler D, Porzelius C, Jörres A, et al. A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients. Crit Care. 2013; 17 (Suppl 2): 62.
11. Peng ZY, Wang HZ, Carter MJ, et al. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int. 2012; 81 (4): 363-369.
12. Bernardi MH, Rinoesl H, Dragosits K, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery-a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016; 20: 96.
13. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008; 36 (5): 1573-1577.
14. Kogelmann K, Druener M, Jarczak D. Observations in early vs. late use of CytoSorb® haemadsorption therapy in critically ill patients. Crit Care. 2016; 20 (Suppl 2): 195.
15. Lees NJ, Rosenberg A, Hurtado-Doce AI, et al. Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton-Valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1. J Artif Organs. 2016; 19 (4): 399-402.
16. David S, Thamm K, Schmidt BM, Falk CS, Kielstein JT. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. J Intensive Care. 2017; 5: 12.